Related Experiment Videos
Vascular endothelial growth factor and angiogenesis
Ann Hoeben1, Bart Landuyt, Martin S Highley
1Laboratory of Experimental Oncology, University Hospital Gasthuisberg, Catholic University of Leuven, Herestraat 49, B-3000 Leuven, Belgium.
Pharmacological Reviews
|December 17, 2004
Summary
Vascular endothelial growth factor (VEGF) drives blood vessel formation in healing, disease, and cancer. Understanding VEGF signaling pathways opens new therapeutic avenues for various conditions.
Area of Science:
- Molecular Biology
- Cell Biology
- Physiology
Background:
- Angiogenesis is crucial for wound healing, the menstrual cycle, cancer, and inflammatory diseases.
- Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and lymphangiogenesis.
- VEGF specifically targets endothelial cells, promoting their proliferation, migration, and new vessel formation.
Purpose of the Study:
- To review the role of VEGF in physiological and pathological processes.
- To explore therapeutic strategies involving the modulation of VEGF expression.
- To highlight recent advancements in the field of VEGF research.
Main Methods:
- Literature review of existing studies on VEGF.
- Analysis of VEGF's role in various biological processes.
- Discussion of therapeutic interventions targeting VEGF.
Main Results:
- VEGF is a potent inducer of angiogenesis and lymphangiogenesis.
- VEGF signaling involves tyrosine kinase receptors, leading to endothelial cell responses.
- Modulation of VEGF expression presents significant therapeutic potential.
Conclusions:
- VEGF plays a central role in both normal physiological functions and disease states.
- Targeting VEGF offers promising therapeutic opportunities for angiogenesis-related disorders.
- Ongoing research continues to uncover new developments in VEGF-based therapies.